Last $9.89 USD
Change Today -0.34 / -3.32%
Volume 63.1K
CNCE On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger D. Tung Ph.D.

Co-Founder, Chief Executive Officer, President and Director, Concert Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 65 board members in 4 different organizations across 4 different industries.

See Board Relationships
53$593,560
As of Fiscal Year 2013

Background*

Dr. Roger D. Tung, Ph.D. Co-founded Concert Pharmaceuticals, Inc. in April 2006 and serves as its President and Chief Executive Officer. Dr. Tung worked in venture-backed start-up and major pharmaceutical companies, including Vertex Pharmaceuticals (NASDAQ: VRTX), where he was a founding scientist, Merck, Sharp and Dohme, and E.R. Squibb & Sons. He served as a Vice President of Drug Discovery for San Diego site of Vertex Pharmaceuticals from February 2002 to January ...

Read Full Background

Corporate Headquarters*

99 Hayden Avenue
Lexington, Massachusetts 02421

United States

Phone: 781-860-0045
Fax: --

Board Members Memberships*

2006-Present
Co-Founder, Chief Executive Officer, President and Director

Education*

PhD
University of Wisconsin - Madison

Other Affiliations*

Annual Compensation*

Salary$373,171
Total Annual Compensation$373,171

Stock Options*

All Other Compensation$8,178

Total Compensation*

Total Annual Cash Compensation$593,560
Total Short Term Compensation$373,171
Other Long Term Compensation$8,178
Total Calculated Compensation$593,560
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CNCE:US $9.89 USD -0.34

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONCERT PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.